![Eytan Ruppin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eytan Ruppin
Plus aucun poste en cours
Historique de carrière de Eytan Ruppin
Anciens postes connus de Eytan Ruppin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Pangea Therapeutics Ltd.
![]() Pangea Therapeutics Ltd. Medical/Nursing ServicesHealth Services Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker. | Fondateur | - | - |
Metabomed Ltd.
![]() Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Fondateur | 01/01/2013 | - |
Soligence Corp.
![]() Soligence Corp. Specialty TelecommunicationsCommunications Soligence Corp. provided cellular expense management solutions. The company was founded by Yuval Spector and Tuvik Beker in 2002 and was headquartered in Palo Alto, CA. | Fondateur | 02/01/2002 | - |
MedAware Ltd.
![]() MedAware Ltd. Packaged SoftwareTechnology Services MedAware Ltd. develops a software platform for the medical prescription market. Its software platform integrated with the electronic health record that detects the likelihood of a medication error. The firm offers alerting and risk management decision support tools. The company was founded by Gidi Stein and Tuvik Beker in 2012 and is headquartered in Raanana, Israel. | Fondateur | - | - |
Statistiques
Internationale
Israël | 4 |
Etats-Unis | 2 |
Opérationnelle
Founder | 4 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Communications | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
MedAware Ltd.
![]() MedAware Ltd. Packaged SoftwareTechnology Services MedAware Ltd. develops a software platform for the medical prescription market. Its software platform integrated with the electronic health record that detects the likelihood of a medication error. The firm offers alerting and risk management decision support tools. The company was founded by Gidi Stein and Tuvik Beker in 2012 and is headquartered in Raanana, Israel. | Technology Services |
Metabomed Ltd.
![]() Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Health Technology |
Soligence Corp.
![]() Soligence Corp. Specialty TelecommunicationsCommunications Soligence Corp. provided cellular expense management solutions. The company was founded by Yuval Spector and Tuvik Beker in 2002 and was headquartered in Palo Alto, CA. | Communications |
Pangea Therapeutics Ltd.
![]() Pangea Therapeutics Ltd. Medical/Nursing ServicesHealth Services Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker. | Health Services |
- Bourse
- Insiders
- Eytan Ruppin
- Expérience